
Brooks Laboratories Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent
2026-06-09 10:00:09At Rs 69.99, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 4.98% on 09 Jun 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Brooks Laboratories Ltd Locks at Lower Circuit With 4.99% Loss — Sellers Queue, No Buyers in Sight
2026-06-02 15:00:07At Rs 65.13, sellers were still queuing — but there were no buyers willing to take the other side. Brooks Laboratories Ltd locked at its lower circuit of 4.99% on 2 Jun 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock.
Read full news article
Brooks Laboratories Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent
2026-06-01 10:00:26At Rs 68.55, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 4.99% on 1 Jun 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Brooks Laboratories Ltd is Rated Sell by MarketsMOJO
2026-05-31 10:10:42Brooks Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Feb 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 31 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Brooks Laboratories Q4 FY26: Profit Plunge Raises Questions on Operational Sustainability
2026-05-30 21:17:48Brooks Laboratories Ltd., a contract manufacturing pharmaceutical company, reported consolidated net profit of ₹1.52 crores for Q4 FY26, marking a sharp decline of 72.36% quarter-on-quarter and a troubling 204.11% year-on-year contraction. The Himachal Pradesh-based micro-cap company, with a market capitalisation of ₹194.00 crores, witnessed its stock surge 5.00% to ₹65.75 following the results announcement, though the broader context reveals a company grappling with severe operational headwinds and margin compression.
Read full news article
Brooks Laboratories Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent
2026-05-29 10:00:18At Rs 65.29, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 5% on 29 May 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Brooks Laboratories Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent
2026-05-27 10:00:23At Rs 62.19, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 5% on 27 May 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Brooks Laboratories Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent
2026-05-26 10:00:24At Rs 59.23, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 5.0% on 26 May 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Brooks Laboratories Ltd Locks at Upper Circuit With 4.99% Gain — Buyers Queue, Sellers Absent
2026-05-25 11:00:28At Rs 56.41, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 4.99% on 25 May 2026, with buyers queuing and no sellers willing to part with shares.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
30-May-2026 | Source : BSENewspaper Publication dated 30th May 2026 of Audited Financial Results for the quarter and year ended 31st March 2026.
Announcement under Regulation 30 (LODR)-Change in Management
29-May-2026 | Source : BSEAppointment of Chief Executive Officer.
Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 29Th May 2026
29-May-2026 | Source : BSEOutcome of Board Meeting held on Held On Friday 29th May 2026.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Brooks Laboratories Ltd has announced 1:16 rights issue, ex-date: 28 Jul 23






